Delivery Order SPE2DB25D3017-SPE2DB25FVHEM

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,287.09 delivery order contract is for the supply of XANAX 1 mg tablets in 100-count bottles. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.93 firm-fixed-price delivery order is for the supply of XANAX 1 MG TABLET 100S, with a period of performance through January 31, 2025. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,188.53 Firm Fixed Price Delivery Order contract covers the supply of 4566769814 XANAX 1 MG TABLET 100S to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,057.72 firm fixed-price contract is for the supply of Xanax 1 mg tablets. The order has an ultimate completion date of August 29, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XANAX 1 MG TABLET 100S, a pharmaceutical product. The award has a Firm Fixed Price pricing type and a ceiling value of $1,847.95. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFJ81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,092.62, is a Firm Fixed Price Delivery Order for 4,567,114,988 units of the prescription drug Xanax 1 mg tablet. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. Amerisourcebergen, a for-profit...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV5VN, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,222.33, is a Firm Fixed Price Delivery Order for the supply of XANAX 0.5 MG TABLET 100S. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xanax 1 mg tablets, with a ceiling value of $2,393.86 and a period of performance through September 6, 2024. This contract is not set aside and is a firm fixed-price contract type. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite delivery contracts...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $2,860.37 to supply 100 tablets of 1 mg Xanax. The delivery order was awarded on December 8, 2023 under an existing indefinite-delivery contract with no set-aside designation specified. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 11, 2023. As a leading pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,451.13 firm fixed price delivery order is for the supply of XELJANZ 10 MG tablet pharmaceuticals. The contract has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHEM
    Delivery Order

This federal contract award, valued at $7,419.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XANAX 1 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/5/25, 10:20 AM